Accumulating evidences have demonstrated that BRD7 is downregulated in many types of cancers, including nasopharyngeal carcinoma [14, 15], ovarian cancer [16], gastric cancer [17], breast cancer [18] and prostate cancer [19]. This evidence concerns the gene BRD7 and nasopharyngeal carcinoma.